Reimbursed with a limitationGenericATC N05AH04

Quetiapin-Mepha retard

Quetiapin-Mepha retard is a generic from Mepha Pharma AG and is listed on the FOPH Specialities List. Basic health insurance reimburses it within the authorised indication. The public price ranges from CHF 49.60 to CHF 273.20 depending on the pack; the co-payment is 10 per cent.

Core data

Authorisation holder
Mepha Pharma AG
ATC code
N05AH04
IT group
01.05 Neuroleptica
Active substances
Quetiapinum
Preparation type
Generic
On the SL since
01/05/2015
Last price change
01/02/2018
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Quetiapin-Mepha retard Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Ret Tabl 50 mg60 StkCHF 30.51CHF 49.6001/05/2015B7680626490015
Ret Tabl 150 mgBlist 60 StkCHF 58.38CHF 79.9001/02/2018B7680626490084
Ret Tabl 150 mgBlist 100 StkCHF 97.30CHF 122.2501/02/2018B7680626490091
Ret Tabl 200 mg60 StkCHF 72.22CHF 94.9501/05/2015B7680626490022
Ret Tabl 200 mg100 StkCHF 118.57CHF 145.3501/05/2015B7680626490039
Ret Tabl 300 mg60 StkCHF 102.06CHF 127.4001/05/2015B7680626490046
Ret Tabl 300 mg100 StkCHF 167.35CHF 198.4001/05/2015B7680626490053
Ret Tabl 400 mg60 StkCHF 141.66CHF 170.5001/05/2015B7680626490060
Ret Tabl 400 mg100 StkCHF 236.10CHF 273.2001/05/2015B7680626490077

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/11/2017

- Behandlung der Schizophrenie (Akutbehandlung und Rückfallprophylaxe).
- Behandlung manischer und depressiver Episoden bei bipolaren Störungen (Akutbehandlung und Rückfallprophylaxe).
- Zusatzbehandlung depressiver Episoden (Episoden einer Major Depression):
Für Patienten, die unzureichend auf die Monotherapie mit mindestens einem Antidepressivum angesprochen haben, im Sinne einer Augmentationsstrategie nach einer gemäss gängigen klinischen Guidelines durchgeführten antidepressiven Therapie. Als Alternative zur Lithiumtherapie bei unzureichendem Ansprechen auf eine Lithiumtherapie, bei bestehender Kontraindikation für eine Lithiumtherapie und bei depressiven Patienten mit psychotischen Symptomen. Vor Beginn der Therapie sollte der behandelnde Arzt das Sicherheitsprofil von Quetiapin-Mepha retard abwägen.

More preparations in this group

FAQ

Is Quetiapin-Mepha retard covered by Swiss health insurance?

Yes, but only under conditions. Quetiapin-Mepha retard is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Quetiapin-Mepha retard cost in Switzerland?

The public price is the maximum price set by the FOPH and for Quetiapin-Mepha retard ranges from CHF 49.60 to CHF 273.20 per pack. The ex-factory price ranges from CHF 30.51 to CHF 236.10. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com